Orforglipron - Oral GLP-1 Receptor Agonist Coming Soon | A New Alternative to Ozempic
Great news! On April 1, 2026, a new oral GLP-1 therapy received FDA approval.
No more injections like Mounjaro or Ozempic — this new treatment comes in a tablet form, making it easier to use in everyday

Foundayo (Orforglipron) works by helping control appetite and blood sugar. It may reduce hunger, help you feel full longer, and support better control of food intake.
It also helps the body manage glucose more steadily and can reduce cravings, which are important for weight management.
Overall, this is a step toward simpler, needle-free treatment options.
We are currently in the process of working with official suppliers, and the product should be available soon on HGHBangkok.com.
Follow updates.
Leave a comment